SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,551
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
South Korea and U.S. Begin Formal Talks on Missile Shield
Hours after a North Korean long-range rocket launch, Washington and Seoul said they were in consultations over the deployment of an...
Merck Posts Lower Revenue and Profit -- 2nd Update
Pay Dividends Or Keep Ratings
Charter Communications Loss Widens on Merger Costs
Online Retailers Find Stores Bring Customers to Web
Wells To Pay $1.2 Billion In Mortgage Accord
Lehman and J.P. Morgan Seek Approval of $1.42 Billion Settlement -- Week Ahead
Redbox Movie Rentals Plunge 24%
Ford to More Than Double Mexico Production Capacity in 2018
Cisco In Deal For Jasper
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 199568 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist